Global Cell Line Development Market - Industry Trends and Forecast to 2026

  • In Vitro Diagnostics
  • Upcoming Report
  • Aug 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Cell Line Development Market By Product (Reagents and Media, Equipment, Accessories and Consumables), Source (Mammalian Cell Line, Non-Mammalian Cell Line), Cell Line Type (Recombinant Cell Lines, Hybridomas, Continuous Cell Lines, Primary Cell Lines), Application (Bio Production, Drug Discovery, Toxicity testing, Vaccines, Tissue Engineering, Research, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Market Analysis: Global Cell Line Development Market

Global cell line development market is set to witness a healthy CAGR of 13.3% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising usage of vaccination globally and increment of patient

Market Definition: Global Cell Line Development Market

Cell line development area unit is widely utilized in variety of necessary applications such as biologics (recombinant macromolecule and organism antibody) production, drug screening, and gene functional studies. The method of evolving stable cell lines usually initiate with transfecting selected host cells, generally CHO or HEK 293 cells, with exact plasmids. Following the transfection, the researchers then screen and identify the high-expressing clones. After the recognition of such high producers the cell lines or the proteins made through the cells get the acceptance.

Market Drivers

  • Worldwide increasing production of vaccines is driving the market growth
  • Increasing variety of cancer incidences particularly in developing countries such as India and China is a driver for the market growth
  • Extension of applications of biotechnology sector is fueling the market growth
  • Rising demand for organism antibodies in U.S. and Europe is a  driver for this market
  • Advancements of technology  in cell line development is boosting the growth of the market

Market Restraints

  • Rough distribution of technology is restraining the growth of the market
  • Growing concerns associated with the stem cell analysis is hampering the market growth
  • Lack of clear regulatory guidelines hampers the growth of the market

Segmentation: Global Cell Line Development Market

By Product

  • Reagents and Media
  • Equipment

    • Incubators
    • Centrifuges
    • Bioreactors
    • Storage equipment
    • Microscopes
    • Biosafety Cabinets 
    • Cell Counters & Viability Analysis Systems 

  • Accessories and Consumables

By Source

  • Mammalian Cell Line
  • Non-Mammalian Cell Line

    • Insects
    • Amphibians

By Cell Line Type

  • Recombinant Cell Lines
  • Hybridomas
  • Continuous Cell Lines
  • Primary Cell Lines

By Application

  • Bio production market
  • Drug discovery
  • Vaccines
  • Toxicity testing
  • Tissue engineering
  • Research
  • Others

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Rest of South America

  • Europe

    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Malaysia
    • Indonesia
    • Thailand
    • Philippines
    • Rest of Asia-Pacific

  • Middle East and Africa

    • South Africa
    • Rest of Middle East and Africa

Key Developments in the Market:

  • In July 2019, Abcam acquired EdiGene Inc, a giant company that focuses on evolving genome editing technologies into novel therapeutics due to the wide extent of diseases into inventive solutions to promote drug discovery. By using high-throughput cell piece of writing platform, EdiGene made the industries huge off-the shelf diploid library over a pair of 2800 single clonal knockout (KO) cell lines targeting over a pair of 2,600 genes human cancer cell lines. This acquisition will help to bring the data to the cell lines market and assist to expand the business
  • In July 2019, Imugene acquired the worldwide license to CF33 from City of Hope Cancer Centre in Los Angeles. It is a chimeric vaccinia poxvirus in the oncolytic virotherapy (OV) field showing more potency than the rest of the OVs in pre-clinical trials conducted to date. Oncolytic virotherapy is leading the field of immunotherapy and the recently heralded leading edge of cancer research. This acquisition will help the company to enhance its portfolio in the market as the oncolytic viruses are attracting the serious attention of big pharma companies

Competitive Analysis:

Global cell line development market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cell line development market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major market competitors currently working in global cell line development market are ATCC, Syngene, Crown Bioscience Inc., Evotec A.G, Catalent,Inc, LakePharma, Inc., TCG Lifesciences Private Limited., Cobra Biologics Ltd, Eurofins Scientific, Abzena Ltd, JHL Biotech, Inc., Charles River, GenScript, MabPlex Inc,  trenzyme GmbH, JSR life Sciences, Cytovance Biologics., General Electric, Lonza, Sartorius AG, Corning Incorporated and others

Research Methodology: Global Cell Line Development Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global cell line development market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions